Nippon Kayaku Co (4272) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
19 Aug, 2025Executive summary
Net sales for FY 2025 reached ¥222.6 billion, up 10.3% year-over-year, with all major business units outperforming the previous year.
Operating income rose to ¥20.4 billion, a 178.1% increase year-over-year, and profit attributable to owners of parent hit a record ¥17.5 billion, up 325.6%, mainly due to a gain on sales of investment securities.
FY 2026 forecasts project net sales of ¥234.6 billion (+5.4%), with slight decreases in operating income and profit expected.
The company continued to implement its mid-term business plan, KAYAKU Vision 2025, focusing on growth and operational improvements.
Dividend forecast for FY2026 is ¥60 per share, unchanged from FY2025.
Financial highlights
Operating income margin improved to 9.2% in FY 2025 from 3.6% in FY 2024.
ROE increased to 6.5% (+4.9pp), and the equity ratio stood at 71.6%.
Ordinary income increased 77.3% year-over-year to ¥22.3 billion.
Comprehensive income declined 44.0% to ¥13.1 billion due to negative other comprehensive income items.
Extraordinary gains included ¥2.2 billion from sales of investment securities; a ¥2.6 billion loss was recorded on security valuations.
Outlook and guidance
FY 2026 expects net sales growth in all business units, but operating income and profit are forecast to decrease slightly due to cost pressures and market factors.
The impact of US tariff measures is not included in FY 2026 forecasts.
Dividend forecast for FY2026 is ¥60 per share, unchanged from FY2025.
Latest events from Nippon Kayaku Co
- Profit attributable to owners of parent rose 30.1% on 4.0% sales growth, outlook steady.4272
Q3 20262 Feb 2026 - Net sales up 4.1% and profit nearly doubled on investment gains despite cost pressures.4272
Q2 202612 Nov 2025 - Strong sales and profit growth driven by Mobility & Imaging and Fine Chemicals; outlook revised up.4272
Q1 202519 Aug 2025 - Sharp profit growth and raised forecasts driven by Mobility & Imaging and Fine Chemicals.4272
Q3 202519 Aug 2025 - Sales and operating income surged, with upward guidance and major treasury stock buybacks.4272
Q2 202519 Aug 2025 - Sales rose but profits fell amid higher costs and global risks; outlook remains cautious.4272
Q1 202619 Aug 2025